Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Addex Therapeutics (ADXN)
NASDAQ:ADXN
Holding ADXN?
Track your performance easily
ADXN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.00 - $27.90
Previous Close$8.11
Volume33.96K
Average Volume (3M)305.83K
Market Cap
$10.96M
Enterprise Value$7.43M
Total Cash (Recent Filing)CHF3.87M
Total Debt (Recent Filing)CHF70.38K
Price to Earnings (P/E)1.9
Beta0.14
Next Earnings
Nov 22, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.38
Shares Outstanding1,043,295
10 Day Avg. Volume69,009
30 Day Avg. Volume305,828
Standard Deviation0.28
R-Squared0.12
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)6.71
Price to Sales (P/S)4.27
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$30.00Price Target Upside295.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Addex Therapeutics News
Ownership Overview
―
Insiders
0.13% Other Institutional Investors
99.87% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ADXN FAQ
What was Addex Therapeutics’s price range in the past 12 months?
Addex Therapeutics lowest stock price was $5.00 and its highest was $27.90 in the past 12 months.
What is Addex Therapeutics’s market cap?
Currently, no data Available
When is Addex Therapeutics’s upcoming earnings report date?
Addex Therapeutics’s upcoming earnings report date is Nov 22, 2024 which is today.
How were Addex Therapeutics’s earnings last quarter?
Addex Therapeutics released its earnings results on Sep 30, 2024. The company reported -$2.712 earnings per share for the quarter, missing the consensus estimate of -$1.42 by -$1.292.
Is Addex Therapeutics overvalued?
According to Wall Street analysts Addex Therapeutics’s price is currently Undervalued.
Does Addex Therapeutics pay dividends?
Addex Therapeutics does not currently pay dividends.
What is Addex Therapeutics’s EPS estimate?
Addex Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Addex Therapeutics have?
Addex Therapeutics has 793,638 shares outstanding.
What happened to Addex Therapeutics’s price movement after its last earnings report?
Addex Therapeutics reported an EPS of -$2.712 in its last earnings report, missing expectations of -$1.42. Following the earnings report the stock price went up 7.956%.
Which hedge fund is a major shareholder of Addex Therapeutics?
Among the largest hedge funds holding Addex Therapeutics’s share is New Leaf Venture Partners, L.L.C.. It holds Addex Therapeutics’s shares valued at N/A.
---
Addex Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$30.00 (295.78% Upside)
$30.00 (295.78% Upside)
Hedge Fund Trend
Decreased
By 50.0K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
35.16%
12-Months-Change
Fundamentals
Return on Equity
-82.60%
Trailing 12-Months
Asset Growth
51.80%
Trailing 12-Months
Company Description
Addex Therapeutics
Addex Therapeutics Ltd is a biopharmaceutical company. The company operates through single segment which includes developing drugs to improve human health. It is focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. In addition, it is also engaged in the development of the dipraglurant and ADX71441 program. The company's geographical area of operations includes Switzerland and Europe.
---
ADXN Stock 12 Month Forecast
Average Price Target
$30.00
▲(295.78% Upside)
Technical Analysis
Aclaris Therapeutics
―
Adaptimmune Therapeutics
―
Adial Pharmaceuticals
―
Aptose Biosciences
―
Best Analysts Covering ADXN
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-20.10%
reiterated a buy rating 2 months ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -20.10% per trade.
---